The present study has demonstrated that meloxicam executes its antitumor effects against HCC by inhibiting cell migration, invasion, adhesion and colony formation, and inducing cell autophagy and apoptosis, in both COX-2-depedent and -independent pathways. Here, PTGS2 is linked to hepatocellular carcinoma.